China Health Group Inc. (SEHK: 8225)
Health Care · Life Sciences Tools & Services · CN
HK$0.08
-1.27% today · -55.4% 1Y
China Health Group Inc. (SEHK: 8225) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $9.89M and employs 33 people.
Over the last twelve months the share price has lost 55.4%, trading between 0.07 and 0.18.
Tweenvest scores China Health Group Inc. across four factors: quality 63/100, value 65/100, growth 58/100. Its strongest factor is value.
8225 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.89M
- Revenue (TTM)
- $4.40M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.31
- 52-week high
- HK$0.18
- 52-week low
- HK$0.07
- Avg volume (3M)
- —
- Shares outstanding
- 995.35M
- Employees
- 33
- Next earnings
- —
About China Health Group Inc.
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.
- ISIN
- KYG2117N1088
- Founded
- 1998
- Listed since
- Jul 10, 2003
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genetic Signatures LimitedASX: GSS | $12.64M | AU$0.08 | -4.76% |
| Malaysian Genomics Resource Centre BerhadKLSE: MGRC | $12.37M | RM0.34 | -4.29% |
| Welgene Biotech Co.,Ltd.TPEX: 6661 | $12.21M | NT$17.00 | -1.16% |
| Fusion Antibodies plcAIM: FAB | $10.77M | £0.06 | -35.50% |
| BioInfra Co., Ltd.KOSDAQ: A199730 | $9.32M | ₩2,575.00 | +185.16% |
| RBC Bioscience CorporationTPEX: 6848 | $9.17M | NT$20.85 | -2.57% |
| Pharma-Bio Serv, Inc.OTCPK: PBSV | $9.16M | $0.40 | -16.67% |
| Memphasys LimitedASX: MEM | $8.57M | AU$0.00 | -20.00% |
Figures last refreshed Oct 11, 2026.